Page 3 - Deals Andm Amp A News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Deals andm amp a. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Deals Andm Amp A Today - Breaking & Trending Today

Asensus weighs $96M Storz offer, takes $20M bridge loan

Asensus Surgical Inc. grabbed a $10 million lifeline from prospective suitor Karl Storz SE & Co. KG, which has offered to buy the cash-strapped company for 35 cents per share or about $96 million. Asensus signed a non-binding letter of intent to consider and negotiate terms after “an extensive period of consideration of various strategic alternatives.” Under certain circumstances, it could access a further $10 million from Storz prior to a merger. Asensus reported in March that its cash runway would tap out in early July. ....

Karl Storz Se Co , Asensus Surgical Inc , Asensus Surgical , Karl Storz , Bioworld Medtech , Asensus Surgical Inc , Karl Storz Se Amp Co Kg , Transenterix Inc , Levita Magnetics International Corp , Cmr Surgical Ltd , Virtual Incision Corp , Deals Andm Amp A , Robotic Surgery ,

Sound decision: Masimo to split off consumer business

Less than two years after acquiring Sound United for $1.025 billion, Masimo Corp. plans to hive off the consumer audio subsidiary along with consumer health products such as its Stork baby monitor and Freedom smart watch and band. The “rushed” announcement made Friday “came after being informed that Politan intended to nominate directors this week,” said activist investor Politan Capital Management. Politan, which owns 8.9% of the company, secured two board seats in a highly contentious proxy battle last year and nominated two more on Monday morning. ....

Masimo Corp , Sound United , Politan Capital , Bioworld Medtech , Masimo Corp , Spin Off , Sound United Llc , Apple Inc , Deals Andm Amp A ,

Novo nabs Cardior in €1B deal, gaining phase II-stage miRNA drug

In what co-founder and CEO Claudia Ulbrich called the “right decision with right partner at the right point in time,” Cardior Pharmaceuticals GmbH agreed to an acquisition by Novo Nordisk A/S in a deal worth up to €1.025 billion (US$1.1 billion) that puts a potentially disease-modifying heart failure candidate in the hands of a big pharma player in the midst of establishing its presence in cardiovascular disease. ....

Claudia Ulbrich , Novo Nordisk , Cardior Pharmaceuticals Gmb , Pharmaceuticals Gmbh , Novo Nordiska S , Cardior Pharmaceuticals Gmbh , Cdr 132l , Heart Disease , Mir 132 , Deals Andm Amp A , Mir 132 Inhibitor , Noncoding Rna , Heart Failure , Cardiac Hypertrophy ,

Nuvation to buy Anheart, cancer pipeline in all-stock deal

Nuvation Bio Inc. said on March 25 it will acquire Anheart Therapeutics Ltd., a U.S.- and China-based precision oncology company, in an all-stock transaction, adding Anheart’s ROS1-inhibiting lung cancer drug, taletrectinib (AB-106), to its pipeline. ....

Nuvation Bio Inc , Anheart Therapeutics Ltd , Nuvation Bio , Nuvation Bio Inc , Anheart Therapeutics Ltd , Ros1 Inhibitor , Lung Cancer , Non Small Cell Lung Cancer , Daiichi Sankyo Co Ltd , Bioworld Asia , Deals Andm Amp A , Small Molecule , Asia Pacific ,

Recoded organisms pioneer Pearl Bio signs $1B Merck deal

Technology of genomically recoded organisms borne out of Yale and Stanford university laboratories and housed at Khosla Ventures-backed Pearl Bio received validation on March 12 through a $1 billion deal signed with Merck & Co. Inc. Cambridge, Mass.-based Pearl, which emerged from stealth last year, is eligible for the funds through up-front, option and milestone payments, plus potential royalties on sales of deal-related products that gain approval. ....

United Kingdom , Pearl Bio , Merck Co , Khosla Ventures Backed Pearl Bio , Merck Amp Co Inc , Recoded Organisms , Deals Andm Amp A , Genomically Recoded Organisms ,